首页> 外文OA文献 >Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

【2h】

Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

机译：药物基因组学和药物遗传学指导的个性化治疗的成本效益：对德国个性化药物批准的活性物质的系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marika Plöthner; Dana Ribbentrop; Jan-Phillipp Hartman; Martin Frank;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany [J] . Ploethner Marika, Ribbentrop Dana, Hartman Jan-Phillipp, Advances in therapy. . 2016,第9期

机译：药物基因组学和药理遗传学指导的个性化治疗的成本效益：对德国批准的个性化药物活性物质的系统评价
2. Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: A paradigm shift [J] . Gupta Pooja D. Indian journal of pharmaceutical sciences. . 2015,第2期

机译：个性化药物的药物遗传学，药物基因组学和阿育吠陀学：范式转变
3. Translating pharmacogenetics and pharmacogenomics: The last 60 years and the rise of collective innovation as a force multiplier for personalized medicine [J] . ChengY., HeY.-J., TangJ., Current pharmacogenomics and personalized medicine . 2014,第1期

机译：翻译药物遗传学和药物基因组学：过去60年以及集体创新作为个性化药物的力量倍增器的兴起
4. DOSIMETRY-BASED TREATMENT PLANNING: PERSONALIZED MEDICINE IN RADIOPHARMACEUTICAL THERAPY [C] . Robert Hobbs 8th International Conference on Isotopes 2014 . 2014

机译：基于剂量疗法的治疗计划：放射性药物治疗中的个性化药物
5. Personalized medicine: Examining the current and future applications of pharmacogenetics and pharmacogenomics. [D] . Veeramani, Swarna. 2017

机译：个性化医学：检查药物遗传学和药物基因组学的当前和将来应用。
6. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany [O] . Marika Plöthner, Dana Ribbentrop, Jan-Phillipp Hartman, -1

机译：药物基因组学和药物遗传学指导的个性化治疗的成本效益：对德国个性化药物批准的活性物质的系统评价
7. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany [O] . Plöthner Marika, Ribbentrop Dana, Hartman Jan-Phillipp, 2016

机译：药物基因组学和药物遗传学指导的个性化治疗的成本效益：对德国个性化药物批准的活性物质的系统评价

Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

著录项

引文网络

相似文献

相关主题

期刊订阅